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Colorectal cancer is the leading cause of malignancy of the gastrointestinal tract. A better
understanding of the molecular and cellular changes that lead to the disease is necessary to
develop early diagnosis and optimal treatment modalities. Rodent models are rapid, repro-
ducible and exhibit an adenoma-carcinoma sequence similar to that found in humans. The
objective of this manuscript is to review the most common chemical carcinogens used to
induce experimental tumors and the usual methods of evaluation.
©  2015 Sociedade Brasileira de Coloproctologia. Published by Elsevier Editora Ltda. All
rights reserved.
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O câncer colorretal é a principal neoplasia maligna do trato gastrointestinal. Um melhor
entendimento dos processos moleculares e celulares é necessário para o desenvolvi-
mento de estratégias que permitam um diagnóstico precoce e um tratamento mais eﬁcaz.
Modelos que utilizam roedores são rápidos, reprodutíveis e permitem o estudo da sequen-
cia  adenoma-carcinoma de forma similar a encontrada em humanos. O objetivo dessemanuscrito é revisar os principais modelos de carcinogênese química e os métodos mais
usuais para avaliac¸ão dos resultados.
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Introduction
Colorectal cancer (CRC) is the most common gastrointestinal
malignancy. Worldwide, CRC is the third most common cancer
in men  and the second in women. In Brazil, a total of 32,000
new cases of CRC are expected in 2015.1,2
Colorectal malignant neoplasms are characterized by an
excessive and uncontrolled growth of abnormal cells originat-
ing from any part of the colon. Unlike benign lesions, cancer
is morphologically different from the normal tissue of origin,
have the ability to invade and destroy surrounding tissues,
metastasis to distant organs and, if left untreated, will lead to
death.
The factors involved in the origin and progression of colon
tumors have been an area of increasing interest. Since the ﬁrst
experiment of colon tumors induction, more  accurate mod-
els and various substances with carcinogenic activity have
been studied. Carcinogen-induced colon cancer, have proved
to share many  similarities with human tumors and signif-
icantly contributed to our actual understanding regarding
cancer pathogenesis.3
The ideal experimental carcinogen should induce neo-
plasms in the colon, however, most agents lack speciﬁcity (e.g.
1,2-dimethylhydrazine, that may induce liver tumors). Repro-
ducibility is another important feature that may be hampered
by the heterogeneous species and lineages of animals, each
with different patterns of drug response. Moreover, there is
no standardization of dose and time of tumor development,
to the various studied drugs.
Rodents are widely accepted models of colorectal carcino-
genesis because of their similarity with humans. Advantages
include rapid, reproducible tumor induction and the possibil-
ity to study the adenoma-carcinoma sequence.4
Natural colorectal carcinogenesis factors may be divided
into two main categories: those related to genetic or environ-
mental factors.
Genetic  factors
The importance of oncogenes and suppressive genes are
widely recognized. Early genetic changes include chromosome
5 (APC) and ras mutations while allelic losses in chromosomes
17 (p53) and 18 (DCC) happen late in the adenoma-carcinoma
sequence.5 A schematic genetic model of the adenoma-
carcinoma sequence is shown in Fig. 1.
Environmental  factors
Diet plays an important role on carcinogenesis and, in some
countries with higher CRC prevalence, an attributed risk of
50% is estimated.6 Geographic variations in CRC incidences
and studies with immigrant populations suggest that lifestyle
factors including poor diet, physical inactivity and alcohol
consumption are associated to an increased risk of CRC. While
increased read meat consumption may be harmful, omega-
3, vitamin D, phenolic compounds and a ﬁber-rich diet may
lower the risk of CRC. Regular physical activity may lower the
risk in 24%; on the other hand, obesity may increase it in 19%.
Although moderate to high doses of alcohol have proven to0 1 6;3  6(1):53–57
be deleterious, some studies have observed a protective effect
when light doses are consumed.7,8
Methods  of  chemical  carcinogenesis
There are two types of chemical agents: (1) direct agents,
that do not need metabolization by the organism to have
the deleterious effect and (2) indirect agents, which are not
active unless enzymatic reactions convert them to an active
form.9
1,2-Dimetilhidrazine  (DMH)
DMH is the metabolic precursor of methylazoxymethanol
(MAM). It is the oldest and the most used carcinogen to induce
tumors in rats. Uptake of DMH is three times greater in the
colon cells compared to the enterocytes. The carcinogenic
effect may be obtained after a single injection or via a series
of weekly injections.10,11 The malignant lesion originates from
the non-dysplastic mucosa and becomes evident after 4–30
weeks after administration of the drug. Even after the admin-
istration of small doses of the drug, up to 80% of the treated
mice can develop adenocarcinoma.12
Azoxymethane  (AOM)
AOM is a metabolite of DMH. Its carcinogenesis mechanism
is attributed to c-fos overexpression, reduced expression of
c-myc and k-ras mutation. These changes are similar to
those observed in spontaneous carcinogenesis in humans.13
Compared to DMH, AOM is more  potent and requires fewer
reactions to its activation, which makes a better option. It is
activated in the liver by N-oxidation, and produces essential
reactive compounds for chemical carcinogenesis (methyla-
zoxymethanol and methyl-diazoxide), which are brought to
the colon through the bloodstream or bile as conjugated glu-
curonide.
Heterocyclic  amines  (HAs)
Among the HAs, 2-amino-3-methylimidazo [4,5-f] quinolone
(IQ) and 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine
(PhIP) have gained attention after proved to be highly muta-
genic and tumorigenic in rodents. They appear to have
target-organ speciﬁcity and can induce malignancies of the
colon, prostate and mammary  glands. Creatinine, sugars and
amino acids from red meat and ﬁsh are the precursors of IQ.
The ﬁnal active compound is formed hepatic metabolization.
Incidence of induced colon cancer may reach 28% after admin-
istering a diet rich in IQ and PhIP, for 52 weeks. They became
not only an interesting model of carcinogenesis but can also
help investigation of chemoprotection effect against cancer,
of some substances.14
Aromatic  aminesIn 1941, Lorenz et al. observed the induction of intestinal
tumors in mice fed with 1,2,5,6-dibenzanthracene and 20-
methyleholanthrene. This effect was also studied by Walpole
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t al. who noticed colon tumor induction in mice, after sub-
utaneous administration of 3,2′-dimethyl-4-aminobiphenyl
DMAB).
After 20 weeks of 50 mg/kg subcutaneous injections of
MAB in male F344 rats multiple adenomas and adenocar-
inomas were induced in 30% of animals fed with low-fat diet
nd in 74% of the animals with high-fat diet.
Fig. 2 – Endoscopic visualization of AOM-induced tence. Adapted from Vogelstein.5
This model has two disadvantages: (1) the need for mul-
tiple injections of DMAB and (2) low speciﬁcity, since tumors
may be induced in other tissues such as adenocarcinoma of
mammary  glands, sarcoma of salivary glands, squamous cell
carcinoma of the ear and skin, gastric squamous cell papil-
loma, sarcoma, lymphoma and urothelial carcinoma of the
bladder.15,16
umors in mice. Adapted from Neufert et al.27
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Alkylnitrosamines
Alkylnitrosamines such as methylnitrosourea (MNU) and N-
methyl-N′-nitro-N-nitrosoguanidine (MNNG) are direct-acting
carcinogens with high afﬁnity and methylation capacity of
speciﬁc DNA regions. Rectal instillation of such compounds
induce sessile and polypoid colorectal tumors in rodents.
Doses of 1–3 mg/week of MNNG instilled per rectum, for 20
weeks, induced tumors in 100% of F344 female rats. The main
disadvantage of this model is the difﬁculty to instill a precise
amount of the drug per rectum.17
Evaluation  of  experimental  models
Histological  method
Optical microscopy can assess cellular changes including
the development of aberrant crypt foci (ACF) that may be
considered a preneoplastic event. The development of ACF
is considered an early marker of a future CRC.18 Tumors
may be classiﬁed as adenomas or adenocarcinomas. Optical
microscopy may also evaluate the differentiation grade and
the level of penetration through the intestinal wall (Tis, T1,
T2, T3 e T4).
Immunohistochemistry
The method consists in associating speciﬁc histochemical
dyes to an antigen-antibody reaction, which can increase the
identiﬁcation rate of tumors. Different antigens can be used
in this method:
Metallothionein (MT): MTs  are low-molecular-weight pro-
teins, rich in cysteine residues, mainly expressed in the liver,
kidney, intestine and brain. They play an important role in
protecting against oxidative stress by binding metals such as
zinc and copper. Elevated MT  levels can be found in cancerous
tissues with high proliferation rates, since they can provide
zinc and copper ions for the metabolism of nucleic acids, pro-
tein synthesis, and other metabolic processes. MT  has become
an important biomarker of preneoplastic lesions of the colon,
where it is predominantly expressed by mutated crypt stem
cells.19
Gamma-H2AX: histones are proteins that compact and
order DNA into nucleosomes. They play an important role
on DNA transcription, replication and repair. H2AX originates
from H2A phosphorylation after DNA damage and is respon-
sible for recruitment of repair proteins. H2AX is, therefore, an
important DNA damage biomarker.20
Vascular endothelial growth factor (VEGF):  angiogenesis is
an essential mechanism for the growth and development of
CRC. VEGF is closely associated with neovascular formation
in colorectal neoplasia. A hypoxic tumor microenvironment
is critical to the neoplastic process and a strong stimulus for
the production of VEGF via hypoxia-inducible factor 1  (HIF-
1).21,22Hypoxia-inducible factor 1: HIF-1 is a dimeric transcrip-
tion factor, which is the key to cellular homeostasis under
hypoxia condition by regulating the expression of various
genes involved in cancer biology.230 1 6;3  6(1):53–57
Anti-COX2: early indications of COX-2 role in CRC develop-
ment came from the observation that patients with Gardner’s
syndrome treated with non-steroidal anti-inﬂammatory
drugs had reduced numbers of adenomas. Indeed, elevated
levels of COX-2 may be found in some adenomas and in
adenocarcinomas. The tumorigenic effect of COX-2 may be
attributed to the production of prostaglandin E (PGE2). A
disruption in the COX-2/PGE2 cascade appears to affect colo-
rectal tumorigenesis by promoting the maintenance and
progression of tumor, increased metastasis rate and even par-
ticipating in tumor initiation.24
Cytokine  assay
The immune response may contribute to neoplastic trans-
formation. Some studies have shown that inhibition of
proinﬂammatory cytokines, such as tumor necrosis factor
alpha (TNF-), may lead to reduction of preneoplastic lesions.
On the other hand, production of proinﬂammatory cytokines
and chemokines by macrophages and mast cells, for example,
may stimulate other cells to produce cytokines with anti-
inﬂammatory activity, such as interleukin-10 (IL-10), which
may contribute to tumor-associated immunosuppression .25
Endoscopy
High-resolution endoscopic devices can assess mucosal
changes consistent with preneoplastic lesions or cancer.
Endoscopic aspects are similar to humans. Vegetating and
ulcerated lesions can be found (Fig. 2). Serial biopsies are
required to diagnose the nature of the lesions. Scores that take
the amount and size of tumors into account should be use to
obtain uniform evaluations.26,27
Conclusion
Experimental models allow us to study the early stages of car-
cinogenesis including the adenoma-carcinoma sequence. A
better understanding of the biochemical and cellular changes
that determine carcinogenesis can help the development of
new methods of diagnosis, as well as better and more  effective
treatment.
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